Human Tissue changes everything

Introducing the first platform designed to precisely replicate the structure and function of human tissue 

Animated image of 3D bioprinted heart ventricle beating by Fluidform Regenerative Medicine

Medicine at the intersection of engineering and biology

FluidForm is transforming medicine by creating human tissue for drug discovery, surgical repair, and organ transplant. By integrating 3D printing, computational and synthetic biology, AI and Machine Learning, and advanced materials science, we are developing human tissue applications that deliver on the promise of Medicine 4.0.

By recreating the complex structure and function of human tissue, FluidForm will revolutionize how drugs are discovered and developed, surgery is performed, and diseased organs are replaced.

 
Stylized rendering of a human heart.

FluidForm Technology

To address the extraordinary need for human tissue in medicine, we have developed a suite of technologies to precisely recreate the structure and function required to use in medical applications. We believe this will fundamentally transform what is possible for patients.

The need for a breakthrough in Medicine

Drug Discovery

A Tech working with Cultured Cells.

85% of drugs that go into the clinic fail to reach patients, driving significant cost and time. Despite massive innovation in microfluidics, organ-on-a-chip, and other in-vitro testing models, we still have limited signal on the best drugs to move into the clinic.

Surgical Repair

Replacement heart valve being readied for surgery.

Today, we repair the body with devices made from metal, plastic, and animal tissue. This approach has revolutionized medicine, yet devices frequently wear out, cause negative reactions, and do not support the re-growth of natural tissue. 

Organ Transplant

Surgical team performing open heart surgery.

Millions of patients each year have damaged or diseased organs that would benefit from a transplant. However, the availability of donor organs is fundamentally limited, addressing less than 1% of the total need.

Adam Feinberg, Chief Technology Officer at Fluidform Bioprinting
We set out to fundamentally change how tissues can be engineered, leveraging the latest advances in synthetic biology, 3D printing, advanced materials, AI and Machine Learning to build tissue inspired by the way the body does.
— Dr. Adam Feinberg, Chief Technology Officer and co-founder, FluidForm

Learn more about our Regenerative Medicine Technology